Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 9,300.00
+100.00 (1.09%)
Oct 31, 2025, 1:40 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 213.97 billion as of October 30, 2025. Its market cap has decreased by -35.87% in one year.
Market Cap
213.97B
Enterprise Value
175.92B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,300.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 213.97B, an increase of 33.53%. That is a compound annual growth rate of 5.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 213.97B | -10.78% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | 2.52T | 1,470.89% |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 664.01T |
| SK hynix | 369.37T |
| LG Energy Solution | 115.83T |
| Samsung Biologics | 85.98T |
| Hyundai Motor Company | 55.49T |
| HD Hyundai Heavy Industries | 55.39T |
| Hanwha Aerospace | 53.46T |
| Doosan Enerbility | 52.45T |